[{"caption":"Table 1: Model performance of on predicting immunotherapy response, including \nstandard RNN approaches (LSTM, LSTM(i), LSTM(s)) instead of the proposed \nSimTA, and our methods with multi-modal and single-modal inputs. \n\n","rows":["risk groups is \u003c","AUC"],"columns":["Ours","LSTM","Ours w / o lab","LSTM ( i )","timeline","Ours w / o radiomics","LSTM ( s )"],"mergedAllColumns":["M ) plot of progression - free survival ( PFS ) , p - value of log - rank test to high / low -"],"numberCells":[{"number":"0.47","isBolded":false,"associatedRows":["AUC"],"associatedColumns":["Ours w / o radiomics"],"associatedMergedColumns":[]},{"number":"0.01.Right:K-Mplotofoverallsurvival(OS),withp\u003c","isBolded":true,"associatedRows":["risk groups is \u003c"],"associatedColumns":["Ours w / o radiomics","timeline","timeline"],"associatedMergedColumns":["M ) plot of progression - free survival ( PFS ) , p - value of log - rank test to high / low -"]},{"number":"0.71","isBolded":false,"associatedRows":["AUC"],"associatedColumns":["LSTM"],"associatedMergedColumns":[]},{"number":"0.71","isBolded":false,"associatedRows":["AUC"],"associatedColumns":["LSTM ( i )"],"associatedMergedColumns":[]},{"number":"0.70","isBolded":false,"associatedRows":["AUC"],"associatedColumns":["LSTM ( s )"],"associatedMergedColumns":[]},{"number":"0.80","isBolded":false,"associatedRows":["AUC"],"associatedColumns":["Ours"],"associatedMergedColumns":[]},{"number":"0.58","isBolded":false,"associatedRows":["AUC"],"associatedColumns":["Ours w / o lab"],"associatedMergedColumns":[]},{"number":"0.01.","isBolded":true,"associatedRows":["risk groups is \u003c"],"associatedColumns":["Ours w / o lab","timeline"],"associatedMergedColumns":["M ) plot of progression - free survival ( PFS ) , p - value of log - rank test to high / low -"]}]}]